Category: News
Dr. Charalambous presents brain aging research at AAIC 2026
No Comments
| News
We are delighted to share that Dr. Eleftheria G. Charalambous, member of the AI & Systems Bioinformatics Unit (Cyprus), led by Dr. Anna Onisiforou, presented our findings at the Alzheimer’s Association International Conference (AAIC) 2026, held 12-15 July in London, United Kingdom. AAIC is the world’s largest meeting dedicated to advancing Alzheimer’s disease and dementia […]
Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine
We are proud to share that our Ph.D., Mr. Morfeas Koumas, recently presented his research as a poster at 2026 Department of Psychology Academic Conference at the University of Cyprus, showcasing work conducted as part of the EloKet project of our lab. His study, titled “Unraveling the Role of Eukaryotic Elongation Factor 2 Kinase in […]
Research spotlight: Alexithymia and emotion regulation across smoking status groups
We are proud to share that our research assistant, Ms. Styliani Kaimakkami, recently presented her research poster at the 2026 Department of Psychology Academic Conference at the University of Cyprus, showcasing work conducted as part of the BioNic project of our lab. Her study, titled “Smoking Away Emotions: Alexithymia and Emotion Regulation Across Smoking Status […]
New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?
We are excited to announce a new publication by Dr. Anna Onisiforou, head of our AI and Systems Bioinformatics Unit Cyprus, published in Open Forum Infectious Diseases. This review paper, titled “The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?”, raises a fundamental question about […]
New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis
Climate change accelerates the breakdown of plastics, increasing our exposure to microplastic-derived compounds, including bisphenols and phthalates, that act as xenoestrogens capable of disrupting hormonal and immune regulation. Separately, Epstein–Barr virus (EBV), which infects over 95% of adults worldwide and persists silently in immune cells, has been increasingly implicated in the development of both Alzheimer’s […]
New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms
We are excited to share our new publication in Neuroscience and Biobehavioral Reviews. This is the first review to systematically compare the neurobiological underpinnings of misophonia and tinnitus. These are two debilitating auditory conditions that exact a significant toll on social functioning and mental health. Although often studied in isolation, both disorders share striking neurobiological […]
Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal
We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been appointed as an Editorial Board Member of Neuropharmacology, one of the leading journals in the field of neuroscience and pharmacology. Neuropharmacology, published by Elsevier, is a premier international journal that publishes high-impact research on the effects of drugs on […]
Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine
The Zanos Lab is pleased to announce the publication of a short review article in the Disease of the Month series of Trends in Molecular Medicine. The article, titled “Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapies,” is authored by Dr. Anna Onisiforou, Mr. Morfeas Koumas, and the lab director, Dr. Panos Zanos. This […]
Dr. Zanos appointed as science communication coordinator for European psychedelics research network
We are pleased to announce that Dr. Zanos has been appointed as Science Communication Coordinator for COST Action CA24130, titled “Psychedelic renaissance: turn on, tune in and drop in” (PSY-NET). This European research network brings together scientists, clinicians, industry partners, and regulatory bodies to advance research on psychedelics for therapeutic applications. Dr. Zanos’ appointment to […]
Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research
We are pleased to announce that Dr. Anna Onisiforou, Senior Scientist and Head of the AI & Systems Bioinformatics Unit of our lab, has secured €100,000 in funding through the ERC Vision program of the Research and Innovation Foundation of Cyprus. This outstanding achievement recognizes Dr. Onisiforou’s innovative research and her leadership in developing computational […]